Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FRM-0334 in FTD-GRN
NCT02149160Phase 2Unknown
- Sponsor
- FORUM Pharmaceuticals
- Start
- Oct 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of FRM-0334 in frontotemporal dementia (FTD), sponsored by FORUM Pharmaceuticals. Status: unknown.
02
Drugs
FRM-0334
03
Conditions
frontotemporal dementia (FTD)
Beyond the preview
Go deeper on NCT02149160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02149160.